Minimal improvement in coronary artery disease risk prediction in Chinese population using polygenic risk scores: evidence from the China Kadoorie Biobank
暂无分享,去创建一个
R. Clarke | Zhengming Chen | Junshi Chen | Yu Guo | Liming Li | Z. Pang | Canqing Yu | Ling Yang | I. Millwood | R. Walters | Yiping Chen | J. Lv | Y. Pang | H. Du | Zhijia Sun | D. Sun | P. Pei | Songchun Yang | D. Sun | J. Si | D. Schmidt | R. Stevens | Robin G Walters | Dong Sun
[1] Xueli Yang,et al. Temporal trend in mortality of cardiovascular diseases and its contribution to life expectancy increase in China, 2013 to 2018 , 2022, Chinese medical journal.
[2] Hao Wang,et al. Development of a Model to Predict 10-Year Risk of Ischemic and Hemorrhagic Stroke and Ischemic Heart Disease Using the China Kadoorie Biobank , 2022, Neurology.
[3] M. Pirinen,et al. Integration of questionnaire-based risk factors improves polygenic risk scores for human coronary heart disease and type 2 diabetes , 2022, Communications biology.
[4] M. Inouye,et al. Prognostic Value of a Polygenic Risk Score for Coronary Heart Disease in Individuals Aged 70 Years and Older , 2021, Circulation. Genomic and precision medicine.
[5] J. Danesh,et al. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. , 2021, European heart journal.
[6] C. Gieger,et al. Comparison of genetic risk prediction models to improve prediction of coronary heart disease in two large cohorts of the MONICA/KORA study , 2021, Genetic epidemiology.
[7] L. Liang,et al. A large-scale genome-wide association analysis of lung function in the Chinese population identifies novel loci and highlights shared genetic aetiology with obesity , 2021, European Respiratory Journal.
[8] P. Donnelly,et al. Integrated Polygenic Tool Substantially Enhances Coronary Artery Disease Prediction , 2021, Circulation. Genomic and precision medicine.
[9] Hongyu Zhao,et al. Interactions between Enhanced Polygenic Risk Scores and Lifestyle for Cardiovascular Disease, Diabetes Mellitus and Lipid Levels. , 2021, Circulation. Genomic and precision medicine.
[10] J. Danesh,et al. Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses , 2021, PLoS medicine.
[11] H. Aburatani,et al. Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease , 2020, Nature Genetics.
[12] A. Khera,et al. Genome-Wide Polygenic Score, Clinical Risk Factors, and Long-Term Trajectories of Coronary Artery Disease , 2020, Arteriosclerosis, thrombosis, and vascular biology.
[13] J. Danesh,et al. Validation of a Genome-Wide Polygenic Score for Coronary Artery Disease in South Asians. , 2020, Journal of the American College of Cardiology.
[14] S. A. Lambert,et al. The Polygenic Score Catalog: an open database for reproducibility and systematic evaluation , 2020, medRxiv.
[15] Marc S. Williams,et al. Predictive Utility of Polygenic Risk Scores for Coronary Heart Disease in Three Major Racial and Ethnic Groups. , 2020, American journal of human genetics.
[16] Audrey Y. Chu,et al. Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers , 2020, Nature Medicine.
[17] C. Robinson-Cohen,et al. Predictive Accuracy of a Polygenic Risk Score Compared With a Clinical Risk Score for Incident Coronary Heart Disease. , 2020, JAMA.
[18] P. Elliott,et al. Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease. , 2020, JAMA.
[19] Gretchen A. Stevens,et al. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions , 2019, The Lancet. Global health.
[20] S. Harikrishnan,et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. , 2018, Lancet.
[21] P. Donnelly,et al. The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.
[22] J. Danesh,et al. Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults , 2018, Journal of the American College of Cardiology.
[23] Mary E. Haas,et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations , 2018, Nature Genetics.
[24] Pim van der Harst,et al. Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease , 2017, Circulation research.
[25] L. Qi,et al. Adherence to Healthy Lifestyle and Cardiovascular Diseases in the Chinese Population. , 2017, Journal of the American College of Cardiology.
[26] C. Iribarren,et al. Clinical Utility of Multimarker Genetic Risk Scores for Prediction of Incident Coronary Heart Disease: A Cohort Study Among Over 51 000 Individuals of European Ancestry , 2016, Circulation. Cardiovascular genetics.
[27] Xueli Yang,et al. Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China) , 2016, Circulation.
[28] L. Wain,et al. Haplotype estimation for biobank scale datasets , 2016, Nature Genetics.
[29] Markus Perola,et al. Genomic prediction of coronary heart disease , 2016, bioRxiv.
[30] P. Visscher,et al. Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores , 2015, bioRxiv.
[31] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[32] Sebastian M. Armasu,et al. A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease , 2015, Nature Genetics.
[33] Diane Lacaille,et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk , 2014 .
[34] V. Salomaa,et al. Genetic Risk Prediction and a 2-Stage Risk Screening Strategy for Coronary Heart Disease , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[35] R. Collins,et al. China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. , 2011, International journal of epidemiology.
[36] Sharon R Grossman,et al. Integrating common and rare genetic variation in diverse human populations , 2010, Nature.
[37] M. Pencina,et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.
[38] F. Harrell,et al. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .
[39] OUP accepted manuscript , 2022, European Heart Journal.